"How Corona has changed the regulatory affairs world" organised by Forum Institut für Management will focus on how rolling submissions for Covid-19 vaccines and drugs could affect future innovative medicine registrations.
Experts on regulatory affairs and representatives from vaccine and drug regulators from Germany and Austria will discuss current issues.
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.